EWING SARCOMA OF BONE
Clinical trials for EWING SARCOMA OF BONE explained in plain language.
Never miss a new study
Get alerted when new EWING SARCOMA OF BONE trials appear
Sign up with your email to follow new studies for EWING SARCOMA OF BONE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for teens with hard-to-treat bone cancer
Disease control OngoingThis study tests a drug called regorafenib in people aged 9 to 21 with bone cancer (osteosarcoma or Ewing sarcoma) that has come back or not responded to standard therapy. The goal is to see if the drug can help control the cancer and to find the right dose. Researchers will also…
Matched conditions: EWING SARCOMA OF BONE
Phase: PHASE1, PHASE2 • Sponsor: Institute of Mother and Child, Warsaw, Poland • Aim: Disease control
Last updated May 14, 2026 12:05 UTC
-
Blood test could forecast bone cancer prognosis
Knowledge-focused OngoingThis study is testing whether a blood test (liquid biopsy) can help predict how well children and young adults with Ewing sarcoma or osteosarcoma will do. Researchers will look for tumor DNA in the blood at diagnosis and see if it relates to cancer returning. The goal is to impro…
Matched conditions: EWING SARCOMA OF BONE
Phase: NA • Sponsor: Dana-Farber Cancer Institute • Aim: Knowledge-focused
Last updated May 15, 2026 11:54 UTC